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Abstract
Background: Gene expression analysis is an important tool in contemporary research, with real-time PCR as the
method of choice for quantifying transcription levels. Co-analysis of suitable reference genes is crucial for accurate
expression normalisation. Reference gene expression may vary, e.g., among species or tissues; thus, candidate genes must
be tested prior to use in expression studies. The domestic cat is an important study subject in both medical research and
veterinary medicine. The aim of the present study was to develop TaqMan® real-time PCR assays for eight potential
reference genes and to test their applicability for feline samples, including blood, lymphoid, endocrine, and gastrointestinal
tissues from healthy cats, and neoplastic tissues from FeLV-infected cats.
Results: RNA extraction from tissues was optimised for minimal genomic DNA (gDNA) contamination without use of
a DNase treatment. Real-time PCR assays were established and optimised for v-abl Abelson murine leukaemia viral
oncogene homolog (ABL), β-actin (ACTB), β-2-microglobulin (B2M), β-glucuronidase (GUSB), hydroxymethyl-bilane
synthase (HMBS), hypoxanthine phosphoribosyltransferase (HPRT), ribosomal protein S7 (RPS7), and tryptophan 5-
monooxygenase activation protein, zeta polypeptide (YWHAZ). The presence of pseudogenes was confirmed for four
of the eight investigated genes (ACTB, HPRT, RPS7, and YWHAZ). The assays were tested together with previously
developed TaqMan® assays for feline glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the universal 18S rRNA
gene. Significant differences were found among the expression levels of the ten candidate reference genes, with a ~106-
fold expression difference between the most abundant (18S rRNA) and the least abundant genes (ABL, GUSB, and
HMBS). The expression stability determined by the geNorm and NormFinder programs differed significantly. Using the
ANOVA-based NormFinder program, RPS7 was the most stable gene in the tissues studied, followed by ACTB and ABL;
B2M, HPRT, and the 18S rRNA genes were the least stable ones.
Conclusion: The reference gene expression stability varied considerably among the feline tissues investigated. No
tested gene was optimal for normalisation in all tissues. For the majority of the tissues, two to three reference genes
were necessary for accurate normalisation. The present study yields essential information on the correct choice of feline
reference genes depending on the tissues analysed.
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Background
The domestic cat is an important study subject not only in
veterinary medicine but also in medical research. It plays
an essential role as a laboratory model for human infec-
tious, hereditary and endocrine diseases and allows the
study of topics such as host-pathogen interactions,
defence mechanisms, and development of prophylactic or
therapeutic regimens. Of importance in this context is not
only the feline immunodeficiency virus, the single natu-
rally occurring animal model for HIV-AIDS pathogenesis
[1,2] and the feline leukaemia virus (FeLV), an important
model for retrovirus and tumour research [3,4], but also
other infectious agents, some related to fatal human dis-
eases [1,5]. Furthermore, in the genome of the cat, various
mutations have been characterised that are associated
with genetic diseases, and 280 phenes have been reported,
136 of which could potentially serve as models for human
hereditary diseases http://omia.angis.org.au/. Models
under investigation include the glycogen storage disease
type IV reported in the Norwegian Forest cat, the only
reported animal model for this pathology [6], or the obes-
ity-associated form of diabetes mellitus in the domestic
cat that is similar to the type 2 diabetes mellitus in
humans [7]. For the latter, the domestic cat presents a val-
uable model for understanding the molecular mecha-
nisms linking obesity to the development of insulin
resistance, hypertension, and atherosclerosis [7]. The
potential of the cat as an animal model and the similari-
ties in genome organisation between humans and felids
[8,9] provide the basis for a wide range of gene expression
studies.
Quantitative real-time PCR assays are a method of choice
for reliable and fast quantification of transcription levels
in gene expression studies, and they are used frequently in
many areas of modern research. Real-time PCR provides
quantification of input templates over a broad linear
range, low sample consumption, rapid throughput of
large sample numbers, and low risk of contamination [10-
12]. Accurate normalisation is of fundamental impor-
tance to obtaining sound results. Normalisation is usually
achieved by simultaneous amplification of reference
genes along with the target gene. Several publications
emphasise the need for more than one reference gene for
exact analysis of transcription levels [13-15]. When select-
ing reference genes, several critical points should be con-
sidered, including a stable, experimentally-independent
expression pattern of the candidate gene, the absence of
processed pseudogenes, an adequate level of expression,
and a lack of potential co-regulation among target and ref-
erence genes [16-18].
For the domestic cat a number of potential reference genes
have been studied using pair-wise correlation analysis
(geNorm) [19] and real-time PCR systems based mainly
on SYBR Green chemistry [13,20-22]. The SYBR Green
principle has the advantage that it is less costly; however,
TaqMan® systems usually have a higher specificity and
lead to less non-specific product formation than SYBR
Green assays. No systematic study using TaqMan® real-
time PCR assays for potential feline reference genes is
available. In addition, no comparisons of pair-wise analy-
sis with ANOVA-based methods (NormFinder) [23] have
been published, and most assays for feline reference genes
were conducted using pathological samples. Data on tis-
sues from healthy cats are largely missing.
Thus, the purpose of the present study was to i) develop
and optimise TaqMan® real-time PCR assays for potential
feline reference genes and ii) evaluate the suitability of
these assays for normalisation in the blood and other tis-
sues from clinically healthy cats and neoplastic tissues.
The earlier tissues were chosen to cover those frequently
included in studies investigating infectious diseases and
immunological, endocrine, metabolic, and inflammatory
disorders. The neoplastic tissues originated from FeLV-
infected cats; the expression of reference genes may differ
in neoplastic tissues [16,24]. For stability comparison of
the potential reference genes, two programs were used: the
ANOVA-based NormFinder and the geNorm.
Methods
Sample collection
All domestic cats included in this study had been in exper-
imental studies officially approved by the veterinary office
of the appropriate Swiss Canton. They were kept in groups
under optimal ethological conditions. Clinically healthy
cats were available from negative control groups, and they
were sacrificed for reasons unrelated to this study. Tissue
samples were collected upon necropsy from 15 clinically
healthy cats (ten neutered males and five intact females).
The tissues were histologically examined and verified to
be free of pathological alterations. They originated from
lymphatic tissues including bone marrow (n = 11),
mesenteric lymph node (n = 10), and spleen (n = 10);
from the endocrine tissues of the adrenal gland (n = 11),
pancreas (n = 13), thyroid (n = 10), and parathyroid (n =
7); from the gastrointestinal tissues of the parotid gland
(n = 9), duodenum (n = 10), and ileum (n = 10); and from
the brain (n = 13), myocardium (n = 10), kidney (n = 14),
and liver (n = 9). The cats ranged in age from 1.25 to 13
years (median age 3.8 years). In addition, EDTA-anticoag-
ulated whole blood samples were collected from 11 spe-
cific pathogen-free (SPF) cats (five males at the age of 0.5
years, five neutered males at 6 years, and two spayed
females at 14 years). Upon necropsy, neoplastic tissues (n
= 12, including tissue from liver (1), spleen (2), kidney
(2), mesenteric lymph node (3), ileum (1), and thymus
(3) were collected from six FeLV-infected cats (three neu-
tered males, one neutered and two intact females; ages ofBMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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3 to 13 years). Five of the cats had been diagnosed with
malignant lymphoma; one had leucosis. All tissues were
snap-frozen upon collection and stored at -80°C until
extraction of nucleic acids.
Nucleic acid extractions
Tissues (30-35 mg, in duplicate) were homogenised prior
to RNA extraction in 350 μl of RLT buffer (Qiagen, Hom-
brechtikon, Switzerland) containing 3.5 μl  β-mercap-
toethanol, together with a 5 mm Ø steel bead (Schieritz &
Hauenstein, Arlesheim, Switzerland) in a Mixer Mill MM
300 (Retsch, Haan, Germany). Samples were then proc-
essed using the RNeasy Mini Kit (Qiagen) following the
manufacturer's recommendations. In a preliminary exper-
iment using selected samples (n = 10), the effect of a
digestion step on the RNA binding silica gel membrane of
the spin column, performed according to the manufac-
turer's instructions with RNase-free DNase, was assessed
(on-column DNase treatment). In addition, for bone mar-
row, lymph node, spleen, and thyroid samples, the RNe-
asy Plus Mini Kit (Qiagen) with genomic DNA (gDNA)
Eliminator spin columns and RLT plus buffer was applied
according to the manufacturer's recommendations. The
presence of contaminating gDNA was assessed using
GAPDH quantitative reverse transcriptase (RT-) PCR with
a minus-reverse transcription control with Reverse Tran-
scriptase qPCR Mastermix (Eurogentec, Seraing, Bel-
gium). RNA was extracted from 1 ml of blood within 60
minutes of collection using the QIAamp RNA Blood Mini
Kit (Qiagen) and stored at -80°C until further use. gDNA
was extracted from tissues using the DNeasy Blood & Tis-
sue Kit (Qiagen). For all RNA and DNA extractions, nega-
tive controls consisting of 100 μl of phosphate buffered
saline were prepared with each batch to monitor for cross-
contamination.
First-strand cDNA synthesis
The RNA yield and the ratio of absorbance at 260 nm to
280 nm (A260/A280 ratio) were measured using the Nano-
Drop ND-1000 Spectrophotometer (NanoDrop Technol-
ogies, Witec, Littau, Switzerland). Samples containing <
10 ng/μl of RNA were excluded from the study. First-
strand cDNA was synthesised in quadruplicate using the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Rotkreuz, Switzerland) and random primers
according to the manufacturer's instructions. The amount
of input RNA in each reaction was calculated to be 2 μg.
The cDNA GAPDH copy number/RNA GAPDH copy
number ratio was calculated as a measure of the efficiency
of the cDNA synthesis; this ratio was used to normalise
the reference gene copy numbers as assessed by quantita-
tive real-time PCR.
Development of real-time PCR assays for feline reference 
genes
Using Primer Express™ software (versions 2 and 3,
Applied Biosystems), primers and TaqMan® probes were
designed for eight potential reference genes: ABL, ACTB,
B2M, GUSB, HMBS, HPRT, RPS7, and YWHAZ (essential
gene-specific data are given in Table 1). The sequences and
information on gene organisation were retrieved from
Ensembl http://www.ensembl.org/index.html, GenBank
http://www.ncbi.nlm.nih.gov and the Genome Annota-
tion Resource Fields (GARFIELD) http://
lgd.abcc.ncifcrf.gov[25]. All systems were designed so that
the predicted amplicons would span exon-exon bounda-
ries (Table 2). The eight primer pairs (Microsynth, Bal-
gach, Switzerland) were tested for amplification of the
appropriate amplicon length using 5 μl of cDNA in a total
volume of 25 μl per reaction on a Rotor-Gene 6000 real-
time rotary analyser (Corbett, Mortlake, Australia) using
Table 1: Specifications of the tested potential feline reference genes
Gene Name Function Accession Number
ABL v-abl Abelson murine leukaemia viral oncogene 
homolog
Protein kinase; regulation of cell cycle, mismatch 
repair, DNA damage response
ENSFCAT000000053061
ACTB β-actin Cytoskeletal structural protein AB0511042
B2M β-2-microglobulin Major histocompatibility complex antigen class I 
receptor activity
NM_0010098762
GAPDH Glyceraldehyde-3-phosphate dehydrogenase Glycolytic enzyme AF0971772
GUSB β-glucuronidase Glycoside hydrolase (carbohydrate metabolism) NM_0010093102
HMBS Hydroxymethyl-bilane synthase
Alias: Porphobilinogen deaminase (PBGD)
Heme synthesis, porphyrin metabolism ENSFCAG000000011601
HPRT Hypoxanthine phosphoribosyltransferase Purine synthesis in salvage pathway EF4536972
RPS7 Ribosomal protein S7 Ribosomal protein NM_0010098322
YWHAZ Tyrosine 3-monooxygenase
Alias: tryptophan 5-monooxygenase activation 
protein, zeta polypeptide
Alias: Phospholipase A2
Mediator of signal transduction EF4586212
18S rRNA Ribosomal RNA X032052
1 Ensembl, (http://www.ensembl.org/index.html) 2GenBankBMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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the TaqMan® Fast Universal PCR Master Mix (Applied Bio-
systems). Thermocycling conditions consisted of an initial
denaturation of 20 s at 95°C, followed by 45 cycles of
95°C for 3 s and 60°C for 45 s. The PCR products were
analysed by gel electrophoresis on 3% agarose gels and
stained with ethidium bromide, and bands were visual-
ised using the Chemigenius2 BioImaging System (Syn-
gene, Cambridge, UK).
In order to test for potential amplification of pseudogenes
or of gDNA, the eight primer pairs were also assayed with
gDNA under the same conditions. Moreover, the possible
presence of pseudogenes for the eight assays was assessed
using the Ensembl Genome Browser. In all PCR assays,
water was used as a negative control.
Optimisation of quantitative real-time PCR assays
After the primers had been tested for correct amplification
of the estimated amplicon length, the eight newly
designed real-time TaqMan® PCR systems were optimised
using cDNA and a 3 × 3 primer matrix with 50, 300, and
900 nM end concentrations. Each of the nine conditions
was run in quadruplicate under the conditions described
above. Moreover, using the best primer concentration,
five different probe (Microsynth) end concentrations (50,
100, 150, 200, and 250 nM) were tested for optimal per-
formance. The optimised assays were tested together with
a feline GAPDH TaqMan® real-time PCR assay developed
previously in our laboratory [26] and a universal 18S
rRNA gene (Applied Biosystems).
Table 2: Details of TaqMan® real-time PCR assays
Gene Oligo Sequence Amplicon
size (bp)
Genomic position 
(exon)
Genomic
(bp)
Detection 
gDNA
Pseudo-
gene
ABL Forward TGTGGCGAGTGGTGATAATACAC 83 2 ~12,000 7 No No
Probe CAGCATCACTAAAGGTGAAAAGCTACGAG
TCCTT 2
2/3
Reverse TCCACTCACCATTCTGGTTGTAA 3
ACTB Forward CAACCGTGAGAAGATGACTCAGA 127 3/4 410 8 (Yes) 11 Yes
Probe TCTCTGTACGCTTCTGGCCGCACC 3 4
Reverse CCCAGAGTCCATGACAATACCA 4
B2M Forward CGCGTTTTGTGGTCTTGGT 84 1 3,270 7 No No
Probe CGGACTGCTCTATCTGTCCCACCTGGA 2 1
Reverse AAACCTGAACCTTTGGAGAATGC 1/2
GAPDH Forward GCCATCAATGACCCCTTCAT 82 1 NA (Yes) 11,12 Yes
Probe CTCAACTACATGGTCTACATGTTCCAGTAT
GATTCCA 4
1/2
Reverse GCCGTGGAATTTGCCGT 2
GUSB Forward CTACATCGATGACATCACCATCAG 80 4 532 9 Yes No
Probe ACCAGCGTGAACCAAGACACTGGGC 3 4/5
Reverse CGCCTTCAACAAAAATCTGGTAA 5
HMBS Forward TGGCAGTGCTGAAAGCCTTA 94 3 554 7 No No
Probe TTGAAATCGTTGCTATGTCCACCACAGG 2 3/4
Reverse TTAGAGAGCGCAGTATCAAGAATCTT 4
HPRT Forward AACTGGAAAGAATGTCTTGATTGTTG 100 4/5 >90,000 7 (Yes) 11 Yes
Probe CACTGGCAAAACAATGCAAACCTTGCTTT 3 6
Reverse GACCATCTTTGGATTATACTGCTTGA 6
RPS7 Forward GTCCCAGAAGCCGCACTTT 74 4/5 ~2,200 10 (Yes) 11 Yes
Probe CGCCGTGCACGACGCGA 5 5
Reverse CACAATCTCGCTCGGGAAAA 5
YWHAZ Forward ACAAAGACAGCACGCTAATAATGC 84 4 2,878 7 (Yes) 11 Yes
Probe CGATGTCCACAATGTCAAGTTGTCTCTCAG
TAAT 3
4/5
Reverse CTTCAGCTTCATCTCCTTGGGTAT 5
18S rRNA 
1
Forward CGGCTACCACATCCAAGGAA NA NA NA NT NT
Probe TGCTGGCACCAGACTTGCCCTC 6 NA
Reverse GCTGGAATTACCGCGGCT NA
1 TaqMan® Gene Expression Assay (Applied Biosystems); 2 5' FAM/3' BHQ-1; 3 5' Yakima Yellow/3' BHQ-1; 4 5' FAM/3' TAMRA; 5 5' TET/3' TAMRA; 
6 5' VIC/3' MGB; 7 Ensembl; 8 For ACTB, the PCR product was sequenced [GenBank: GQ848333]; it showed the highest identity to the human actin 
isoform gamma 1 [GenBank: NG_011433]. 9 According to the Genome Annotation Resource Fields (GARFIELD) http://lgd.abcc.ncifcrf.gov[25]; 10 
According to Penning et al. [13]; 11 Amplification of processed pseudogene; 12 According to Leutenegger et al. [26]; NA = Not available; NT = Not 
testedBMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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Production of DNA standards for absolute quantification
cDNA synthesised from feline tissue samples was used to
generate standard templates for absolute quantification of
ABL, ACTB, B2M, GUSB, HMBS, RPS7, and YWHAZ. The
corresponding sequences were amplified using primers
enclosing the TaqMan® real-time PCR sequences under
conditions described (Table 3) [27]. The gel purified
amplification products (Gen Elute PCR Clean-Up Kit,
Sigma-Aldrich, Buchs, Switzerland) were subjected to a 3'
A-tailing reaction (Sigma) and ligated into the TOPO TA
cloning vector pCRII (Invitrogen, Basel, Switzerland),
selected by Ampicillin resistance, followed by sequencing
(Microsynth). Plasmids were linearised by restriction
digestion with BamHI (Promega, Wallisellen, Switzer-
land), SpeI (New England BioLabs, Berverly, MA, USA), or
KpnI (Roche, Rotkreuz, Switzerland) and then gel puri-
fied. The copy numbers were calculated based on spectro-
photometric analysis (NanoDrop ND-1000). Carrier
salmon sperm DNA (Invitrogen) at a concentration of 30
μg/ml was used for the tenfold serial dilutions of the
standard templates, and aliquots of the dilutions were
stored at -20°C until use. For the GAPDH assay, the DNA
standard described previously [26] was used. For the
HPRT and 18S rRNA assays, cDNA from kidney tissue of a
clinically healthy cat was diluted tenfold in carrier salmon
sperm DNA and in nuclease free water, respectively, to
produce an arbitrary standard. The copy numbers of the
latter samples were estimated by matching the resulting
threshold cycle (Ct) values with those of the feline
GAPDH standard.
Efficiency, sensitivity, linear range and precision of the 
real-time PCR assays
The efficiency of the newly designed assays was calculated
as described [28] using the following equation: E = (10(-1/
slope))-1. The sensitivity of the seven new systems (for
which DNA standards had been produced) was deter-
mined by an endpoint dilution experiment: ten replicates
of the dilutions containing 102, 101, and 100 standard
template copies per reaction, respectively, were tested. The
sensitivity of the assay is given by the dilution in which at
least seven of 10 replicates are still positive [29]. The lin-
ear range of amplification and the precision of all newly
developed TaqMan®  real-time PCR assays were deter-
mined using tenfold serial dilutions of the plasmid or
arbitrary standards. For the precision analysis, the dilu-
tions were chosen according to the ranges of Ct values that
were characteristic for the expression levels of the particu-
lar reference genes in the tissues. Intra-run (n = 10) and
between-run (n = 5) analytical performances of the PCR
measurements were determined using these control mate-
rials.
Data evaluation and statistics
For stability comparison of candidate reference genes, the
Microsoft Excel Add-in NormFinder [23] was applied.
Comparisons were made with calculations performed
using the geNorm version 3.4 [19]. The NormFinder uses
an ANOVA-based model [23], while the geNorm calcu-
lates the stability using a pairwise comparison model [19].
In addition, the geNorm ranks candidate reference genes
according to the average expression stability, M  [19].
Genes with the lowest M  values have the most stable
expression; a cut-off of 1.5 was proposed, above which the
variation is assumed to be too high for accurate normali-
sation [19]. Moreover, the optimal number of reference
genes required for accurate normalisation was estimated
using the geNorm. To this end, the pairwise variation Vn/
n+1 between sequential normalisation factors containing
an increasing number of reference genes was calculated. If
Vn/n+1  < 0.15, the recommended number of reference
genes is given by n; the inclusion of an additional refer-
ence gene is not required [19]. Statistical analyses were
performed with GraphPad Prism for Windows, Version
Table 3: Primers used for production of standard templates
Gene Forward Primer
Reverse Primer
Sequences Annealing
Temperature (°C)
Amplification
product (bp)
ABL fABL_StdF GGCTTTGAGGGAGACAAGAC 62 402
fABL_StdR GAAGCTGCCATTGATCAGAC
ACTB fACTB_StdF CCATCGAACACGGCATTGTCAC 58 431
fACTB_StdR CTTGATGTCACGCACAATTTCCCG
B2M fB2M-F GGCGCGTTTTGTGGTCTTGGTC 63 339
fB2M-R CACTTAACGACCTTGGGCTC
GUSB fGUSB_StdF GCCGCATTACCATTGCCATCAAC 64 384
fGUSB_StdR GCATCAGGTATGGCCACCAGAG
HMBS fHMBS_StdF CAGCCCAAAGATGAGAGTGATTCG 64 339
fHMBS_StdR GGGTGAAAGACAACGGCATCATAG
RPS7 fRPS7-F AGCTGAGGGAGCTGAACATC 65 432
fRPS7-R TGCCCGTGAGCTTCTTATAG
YWHAZ fYWHAZ_StdF GAGGTTGCTGCTGGTGATGAC 64 329
fYWHAZ_StdR CCTGCTTCAGCTTCATCTCCTTGGBMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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4.03 (GraphPad software, San Diego, CA). Expression lev-
els of individual genes in different tissues were tested for
statistical differences among several groups using the non-
parametric Kruskal-Wallis test (pKW) and the Dunn's
Multiple Comparison Test (pD). The expression levels of
different genes in individual samples were tested for sta-
tistical differences between two groups using the non-par-
ametric Wilcoxon signed rank test for paired samples
(pW) and among several groups using the non-parametric
Friedman test for paired samples (pF) and the Dunn's
Multiple Comparison Test (pD). P-values < 0.05 were
considered significantly different.
Results
RNA extractions and gDNA contamination
RNA extractions from blood using the QIAamp Blood
Mini Kit and from tissues using the RNeasy Mini Kit
yielded RNA with a low level of contaminating gDNA (<
1%), with the exceptions of bone marrow, lymph node,
spleen, and thyroid. When RNA extraction was performed
for these four tissues using the RNeasy Plus Mini Kit, con-
taminating gDNA levels were < 1%. These additionally
processed RNA samples were used for analysis of these
four tissues. No on-column DNase treatment was used in
the main experiment because the loss of RNA due to
DNase treatment was > 85%, as determined in a prelimi-
nary experiment (data not shown). RNA purity was esti-
mated from A260/A280 ratio; this ratio ranged from 1.7 to
2.1.
Evaluation of the primer pairs
When the primers were tested in a conventional PCR with
cDNA, all assays yielded PCR products of the predicted
size (Table 2). The primers were then assessed using the
same procedure and gDNA to test for the amplification of
gDNA and the possible presence of pseudogenes. Bands of
the size of the cDNA were found for ACTB, HPRT, RPS7,
and YWHAZ, indicating the presence of processed pseu-
dogenes for these genes, but not for ABL, B2M, HMBS,
and GUSB (Table 2). This was consistent with the results
retrieved from Ensembl. In addition, for ACTB, GUSB,
and HMBS, PCR products presumably of the size of the
gDNA, including the introns, were detected (Table 2).
Evaluation and optimisation of the newly developed real-
time PCR assays
Primer and probe concentrations for the eight newly
designed TaqMan® real-time PCR assays were optimised
using cDNA (for final concentrations see Table 4). When
the real-time TaqMan® PCR assays were tested using gDNA
instead of cDNA, specific amplification was found for
ACTB, HPRT, RPS7, and YWHAZ, confirming the presence
of pseudogenes (Table 2). In addition, amplification was
detected for GUSB (Table 2).
Efficiency, sensitivity, linear range and precision of the 
real-time PCR assays
The amplification efficiencies of the eight newly designed
assays and the feline GAPDH real-time PCR were ≥96%.
The lower detection limit of the assays for ABL, ACTB,
B2M, GUSB, RPS7, and YWHAZ was equal to one copy of
target standard plasmid per reaction in an endpoint dilu-
tion experiment (7 to 10 out of 10 reactions positive). For
HMBS the lower limit of detection was < 100 copies per
reaction (10 out of 10 reactions positive). For all newly
developed TaqMan® real-time PCR assays, we observed
linearity of the assay over a ≥108-fold range. The coeffi-
cients of variation ranged from 0.44% (B2M) to 1.18%
(YWHAZ) for the intra-run precision analysis and from
0.49% (ACTB) to 2.15% (HMBS) for the between-run
analysis.
Expression levels of candidate reference genes
Transcription of the ten candidate reference genes was
detectable above background in all tissue and blood sam-
ples from all cats tested. The potential reference genes
were classified into three groups according to their tran-
scription levels (all healthy tissues and blood samples
were included in the analysis; Figure 1a). The difference in
median expression levels was 106 between the most abun-
dant and least abundant transcripts: 18S rRNA showed a
high transcription level (median copy number/reaction
~109); ACTB, GAPDH, B2M, HPRT, and RPS7 were found
to have intermediate transcription levels (median copy
number/reaction 2.6 × 104 to 9.3 × 104), and ABL, GUSB,
and HMBS had low transcription levels (median copy
number/reaction 0.5 × 103  to 1.9 × 103; Figure 1a).
YWHAZ had a transcription level between the intermedi-
ate and low levels (median copy number/reaction 6.9 ×
103). Individual candidate reference genes had different
expression levels across all studied tissues; the transcrip-
tion levels differed significantly among all different refer-
ence genes when all tissues were included in the analysis
(pF < 0.0001; pD < 0.05), with the exceptions of ACTB,
GAPDH and B2M; GUSB and HMBS; and HPRT and RPS7
Table 4: Optimal final concentration of primers and probe for 
the newly designed real-time PCR assays
Real-time PCR 
assay
Forward 
Primer
(nM)
Reverse 
Primer
(nM)
Prob
e
(nM)
ABL 300 900 50
ACTB 900 900 50
B2M 300 900 100
GUSB 900 300 100
HMBS 900 900 250
HPRT 900 900 50
RPS7 50 900 200
YWHAZ 900 900 150BMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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Expression levels of candidate reference genes in different tissues Figure 1
Expression levels of candidate reference genes in different tissues. a) All healthy tissues combined, b) adrenal gland, c) 
bone marrow, d) myocardium, e) brain, and f) blood samples. Values are given as copy numbers per PCR. For the 18S rRNA 
gene and HPRT the copy numbers were calculated using an arbitrary standard (see M&M). Data are shown as box plots. Boxes 
extend from the 25th to the 75th percentile; a horizontal line represents the median, and the error bars extend down to the 
smallest and up to the largest value. Expression levels were analyzed for statistical differences using the Friedman test (pF-val-
ues as indicated in the figure). Significant differences between two particular genes were analyzed by the Wilcoxon test for 
paired samples (asterisks and circles, respectively, mark statistically significant differences between two genes; pW ≤ 0.0039).
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(Figure 1a). The latter three groups of reference genes did
not have significantly different transcription levels (pD >
0.05; Figure 1a). A reference gene transcription level pat-
tern similar to that seen in all tissues combined was found
when individual tissues were examined (for a representa-
tive example, see Figure 1b), with the following particular
exceptions. In the bone marrow samples HMBS transcrip-
tion was significantly higher than GUSB transcription
(pW = 0.0010; Figure 1c), in the myocardium and brain
samples GAPDH transcription was significantly higher
than B2M transcription (pW = 0.0020; Figure 1d and 1e),
in the blood B2M and ACTB transcription levels were
higher than GAPDH transcription (pW = 0.0039; Figure
1f), and in the liver YWHAZ was significantly lower than
RPS7 and HPRT (pW = 0.0039, data not shown). When
expression levels of the individual potential reference
genes were analysed among different tissues significant
differences were found. The most prominent were the fol-
lowing: GAPDH was significantly higher in the myocar-
dium, brain, and blood samples than in most of the other
tested tissues (pKW < 0.0001; pD < 0.001 for 11 of the
other tested tissues; Figure 2a); ABL was significantly
lower in the bone marrow samples than in the majority of
the other tested tissues (pKW < 0.0001; pD < 0.001 for
eight of the other tested tissues; Figure 2b), B2M was
higher in the blood samples (pKW < 0.0001; pD < 0.001
for twelve of the other tested tissues; Figure 2c), and
YWHAZ was higher in the blood and brain samples than
Expression levels of selected reference genes in individual tissues Figure 2
Expression levels of selected reference genes in individual tissues. a) GAPDH, b) ABL, c) B2M, and d) YWHAZ. Val-
ues are given as copy numbers per PCR. Data are shown as box plots. Boxes extend from the 25th to the 75th percentile; a 
horizontal line represents the median, and the error bars extend down to the smallest and up to the largest value. Expression 
levels were tested for statistical differences by the Kruskal-Wallis test (pKW-values as indicated in the figure) and the Dunn's 
post test (asterisks indicate statistically significant differences; pD < 0.001).
Adrenal gland
Pancreas
Parathyroid
Thyroid
Bone marrow
Lymph node
Spleen
Parotid gland
Duodenum
Ileum
Liver
Kidney
Myocardium
Brain
Blood
Tumor
       1000
       1002
       1004
       1006
       1008
       1010
G
A
P
D
H
 
c
D
N
A
 
(
c
o
p
i
e
s
/
r
e
a
c
t
i
o
n
)
a.
Adrenal gland
Pancreas
Parathyroid
Thyroid
Bone marrow
Lymph node
Spleen
Parotid gland
Duodenum
Ileum
Liver
Kidney
Myocardium
Brain
Blood
Tumor
       1000
       1002
       1004
      10 06
       1008
       1010
A
B
L
 
c
D
N
A
 
(
c
o
p
i
e
s
/
r
e
a
c
t
i
o
n
)
b.
Adrenal gland
Pancreas
Parathyroid
Thyroid
Bone marrow
Lymph node
Spleen
Parotid gland
Duodenum
Ileum
Liver
Kidney
Myocardium
Brain
Blood
Tumor
       1000
       1002
       1004
       1006
       1008
       1010
B
2
M
 
c
D
N
A
(
c
o
p
i
e
s
/
r
e
a
c
t
i
o
n
)
c.
Adrenal gland
Pancreas
Parathyroid
Thyroid
Bone marrow
Lymph node
Spleen
Parotid gland
Duodenum
Ileum
Liver
Kidney
Myocardium
Brain
Blood
Tumor
       1000
       1002
       1004
       1006
       1008
       1010
Y
W
H
A
Z
 
c
D
N
A
(
c
o
p
i
e
s
/
r
e
a
c
t
i
o
n
)
d.
* *
*
*
* *
*
pKW < 0.0001 pKW < 0.0001
pKW < 0.0001 pKW < 0.0001BMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
Page 9 of 14
(page number not for citation purposes)
in the majority of the other tissue samples (pKW < 0.0001;
pD < 0.001 for 11 and 12, respectively, of the other tested
tissues; Figure 2d). No particular differences in expression
levels were observed when the neoplastic tissues were
compared to the healthy tissues (pW > 0.05 for all genes
tested; data not shown).
Expression stability of candidate reference genes in 
different tissues
The stability of reference gene expression was estimated
based on the calculations of the geNorm and NormFinder
software, and the rank order given by the two programs
differed significantly (Table 5; for details see also Addi-
tional Files 1 and 2). However, partial agreement was
found between the NormFinder results and the results
according to the M values of the geNorm program (Table
5); for three tissues (bone marrow, duodenum, and kid-
ney) the rank order was identical. The two genes that
ranked best were identical with both methods (manual M
value ranking and NormFinder) for the majority of the tis-
sues except for lymph node, parotid gland, liver, and
blood samples. All further stability analyses were made
using the NormFinder results.
The stability of the genes varied considerably depending
on the tissues tested. When tissues were analysed individ-
ually, no single gene was found among the three best-
ranked genes in all of the tested tissues. In 11 of the 14
healthy tissues, RPS7 ranked among the three most stable
genes, followed by ACTB in eight and ABL in six out of 14
tissues (Table 5). Less stable were GUSB and YWHAZ; they
were among the most stable genes in five of the 14 tissues
used. GAPDH was among the three most stable genes in
the NormFinder ranking in four out of 14 tissues. HMBS,
B2M, HPRT, and 18S rRNA were the least stable, HMBS
with two, B2M and HPRT with one, and 18S rRNA with
no rankings among the most stable genes in the 14 tissues
tested. When all 14 healthy tissues were included at once
in the analysis (Table 5), RPS7, GUSB, and YWHAZ
ranked as the best three reference genes, while ABL and
ACTB ranked fourth and fifth. Exceptions were found in
certain healthy tissues; RPS7 was less stable in the ileum,
lymph node, and thyroid samples. Moreover, ACTB
ranked last in the pancreas samples (Table 5). In the
blood samples, GAPDH and B2M ranked better than in
other tissues, but RPS7 ranked only second to last (Table
5). Remarkably, in the neoplastic tissues the two most sta-
ble genes were identical to those in all the healthy tissues
(RPS7 and ACTB). ABL, GUSB, and YWHAZ were less sta-
ble than in the healthy tissues (Table 5).
Number of reference genes for optimal normalization
The optimal number of reference genes for normalisation
was calculated using the geNorm program. The number of
recommended reference genes for optimal normalisation
varied considerably depending on the tissue being tested.
For brain, myocardium, lymph node, and adrenal gland
the pairwise variation V2/3 was ≤ the proposed cut-off of
0.15 (Additional File 2); therefore, two reference genes
should be sufficient for accurate normalisation in those
tissues. Similarly, for parathyroid, parotid gland, liver and
kidney, three; for thyroid, four; for spleen and neoplastic
tissues, five; and for blood, seven reference genes were
necessary for accurate normalisation according to the
geNorm program (Additional File 2). For four tissues the
pairwise variation V always exceeded the cut-off of 0.15.
The recommended number of reference genes for these
four tissues (lowest V value) was: five for the pancreas, six
for ileum and bone marrow, and seven for the duodenum
(Additional File 2). For all tissues combined, the optimal
number of reference genes that would have been neces-
sary for normalisation exceeded ten using the reference
genes tested in this study. For the three tissue groups,
endocrine, lymphatic, and gastrointestinal tissues, the V
value always exceeded the cut-off of 0.15; the recom-
mended number of reference genes for these tissue groups
(lowest V value) was six (Additional File 2).
Normalisation
When tissues were analysed individually, a normalisation
factor was calculated for all tissues with the exception of
the pancreas. For the latter, all M values calculated by
geNorm exceeded the proposed cut-off value of 1.5, and
no normalisation factors based on the geometric mean of
multiple reference genes could be computed (Additional
File 2). When tissue groups were analysed, a normalisa-
tion factor was calculated for the endocrine and gastroin-
testinal tissues but not for the lymphatic group. No
normalisation factor was calculated for all tissues com-
bined.
Discussion
The present study is the first to develop and evaluate real-
time TaqMan® assays for the quantification of a series of
potential feline reference genes. The assays were applied
using feline peripheral blood and tissue samples from
healthy cats. The latter were chosen based on their appli-
cability in research areas such as the investigation of
immune functions or metabolism, characterisation of
infections, inflammatory reactions, or excretion patterns
of pathogens. In this regard, the selected tissue categories
also met the claim of suitability regarding their potential
use in animal models for several human diseases. The
expression stability of potential reference genes was ana-
lysed and compared for the feline species for the first time
using pair-wise and ANOVA-based analyses; the two
methods yielded discrepant results concerning the gene
expression stability.
We selected ten commonly used mammalian reference
genes featuring a broad range of cellular functions (Table
1). Some other potential candidate genes, such as Cyclo-BMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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Table 5: Ranking of potential reference genes according to the expression stability
Tissues Analsysis Ranking
All endocrine tissues tested NF YWHAZ > GUSB > B2M > RPS7> HMBS > ABL > 18S > GAPDH > ACTB > HPRT
gN(M) B2M > GUSB > YWHAZ > HMBS > RPS7 > ABL > 18S > GAPDH > ACTB > HPRT
gN B2M = HMBS > GUSB > YWHAZ > RPS7 > ABL > 18S > GAPDH > ACTB > HPRT
Adrenal gland NF HPRT > RPS7 > ABL > B2M > ACTB > GAPDH > 18S > HMBS > YWHAZ > GUSB
gN(M) HPRT > RPS7 > ABL > ACTB > B2M > 18S = GAPDH > HMBS > YWHAZ > GUSB
gN GAPDH = 18S > RPS7 > HPRT > YWHAZ > ABL > B2M > ACTB > HMBS > GUSB
Pancreas NF RPS7 > GUSB > YWHAZ > HMBS > B2M > GAPDH > ABL > 18S > HPRT > ACTB
gN(M) RPS7 > GUSB > YWHAZ > B2M > HMBS > ABL > GAPDH > 18S > HPRT > ACTB
gN GUSB = RPS7 > YWHAZ > HMBS > B2M > ABL > 18S > GAPDH > HPRT > ACTB
Parathyroid NF ACTB > RPS7 > GAPDH > HMBS > YWHAZ > ABL > B2M > GUSB > 18S > HPRT
gN(M) ACTB > RPS7 > GAPDH > ABL > HMBS > YWHAZ > B2M > GUSB > 18S > HPRT
gN GAPDH = RPS7 > ACTB > HMBS > ABL > YWHAZ > B2M > GUSB > 18S > HPRT
Thyroid NF GUSB > ACTB > YWHAZ > HMBS > B2M > RPS7 > ABL > 18S > GAPDH > HPRT
gN(M) ACTB > GUSB > YWHAZ > B2M > HMBS > RPS7 > ABL > 18S > GAPDH > HPRT
gN ACTB = HMBS > GUSB > B2M > YWHAZ > RPS7 > ABL > 18S > GAPDH > HPRT
All lymphoid tissues tested NF RPS7 > GUSB > ACTB > YWHAZ > ABL > GAPDH > B2M > HPRT > 18S > HMBS
gN(M) GUSB > RPS7 > ACTB > YWHAZ > ABL > B2M > GAPDH > HPRT > 18S > HMBS
gN GUSB = RPS7 > ACTB > YWHAZ > ABL > B2M > GAPDH > HPRT > 18S > HMBS
Bone marrow NF RPS7 > HMBS > ABL > GUSB > YWHAZ > ACTB > B2M > 18S > HPRT > GAPDH
gN(M) RPS7 > HMBS > ABL > GUSB > YWHAZ > ACTB > B2M > 18S > HPRT > GAPDH
gN ACTB = YWHAZ > HMBS > GUSB > RPS7 > ABL > B2M > 18S > HPRT > GAPDH
Lymph node NF GUSB > ACTB > B2M > HMBS > YWHAZ > ABL > RPS7 > GAPDH > 18S > HPRT
gN(M) GUSB > B2M > ACTB > YWHAZ > ABL > HMBS > RPS7 > GAPDH > 18S > HPRT
gN ABL = B2M > YWHAZ > ACTB > GUSB > HMBS > GAPDH > RPS7 > 18S > HPRT
Spleen NF GUSB > RPS7 > ACTB > ABL > B2M > HMBS > YWHAZ > HPRT > GAPDH > 18S
gN(M) GUSB > RPS7 > ACTB > B2M > ABL > HMBS > YWHAZ > HPRT > GAPDH > 18S
gN ACTB = B2M > GUSB > RPS7 > ABL > HMBS > YWHAZ > HPRT > GAPDH > 18S
All gastrointestinal tissues tested NF ACTB > HMBS > YWHAZ > RPS7 > ABL > GAPDH > GUSB > B2M > 18S > HPRT
gN(M) ACTB > HMBS > YWHAZ > RPS7 > ABL > GAPDH > GUSB > B2M > 18S > HPRT
gN ABL = HMBS > RPS7 > ACTB > YWHAZ > GAPDH > B2M > GUSB > 18S > HPRT
Parotid gland NF ABL > ACTB > RPS7 > YWHAZ > HMBS > B2M > HPRT > GAPDH > GUSB > 18S
gN(M) ABL > RPS7 > ACTB > YWHAZ > HMBS > B2M > HPRT > GAPDH > GUSB > 18S
gN ABL = ACTB > HMBS > RPS7 > YWHAZ > B2M > HPRT > GAPDH > GUSB > 18S
Duodenum NF RPS7 > GAPDH > ACTB > HMBS > YWHAZ > ABL > 18S > GUSB > B2M > HPRT
gN(M) RPS7 > GAPDH > ACTB > HMBS > YWHAZ > ABL > 18S > GUSB > B2M > HPRT
gN ACTB = HMBS > RPS7 > GAPDH > YWHAZ > ABL > 18S > GUSB > B2M > HPRT
Ileum NF HMBS > ABL > YWHAZ > ACTB > GAPDH > GUSB > RPS7 > HPRT > B2M > 18S
gN(M) HMBS > ABL > ACTB > YWHAZ > GAPDH > GUSB > RPS7 > HPRT > B2M > 18S
gN YWHAZ = ACTB > HMBS > ABL > GUSB > GAPDH > RPS7 > HPRT > B2M > 18S
Liver NF GUSB > GAPDH > RPS7 > HPRT > HMBS > YWHAZ > ABL > ACTB > B2M > 18S
gN(M) GAPDH > HMBS > HPRT > GUSB > RPS7 > YWHAZ > ABL > ACTB > B2M > 18S
gN ACTB = HMBS > ABL > GAPDH > HPRT > GUSB > YWHAZ > RPS7 > B2M > 18S
Kidney NF YWHAZ > RPS7 > ABL > ACTB > HMBS > GUSB > GAPDH > B2M > HPRT > 18S
gN(M) YWHAZ > RPS7 > ABL > ACTB > HMBS > GUSB > GAPDH > B2M > HPRT > 18S
gN RPS7 = YWHAZ > ABL > ACTB > HMBS > GAPDH > GUSB > B2M > HPRT > 18S
Myocardium NF ACTB > RPS7 > GAPDH > HMBS > YWHAZ > ABL > GUSB > 18S > HPRT > B2M
gN(M) RPS7 > ACTB > GAPDH > YWHAZ > HMBS > ABL > GUSB > 18S > HPRT > B2M
gN GAPDH = YWHAZ > RPS7 > ACTB > HMBS > ABL > GUSB > 18S > HPRT > B2M
Brain NF ACTB > ABL > RPS7 = YWHAZ > HMBS > GAPDH > HPRT > GUSB > B2M > 18S
gN(M) ACTB > ABL > RPS7 > YWHAZ > HPRT > GAPDH > HMBS > GUSB > B2M > 18S
gN ABL = RPS7 > ACTB > GAPDH > HPRT > YWHAZ > HMBS > GUSB > B2M > 18S
All healthy tissues combined NF RPS7 > GUSB > YWHAZ > ABL > ACTB > B2M > HMBS > 18S > GAPDH > HPRT
gN(M) RPS7 > GUSB > YWHAZ > ABL > ACTB > B2M > HMBS > 18S > GAPDH > HPRT
gN GUSB = RPS7 > ABL > YWHAZ > ACTB > B2M > HMBS > 18S > GAPDH > HPRT
Blood NF YWHAZ > ABL > GAPDH > B2M > ACTB > GUSB > 18S > HPRT > RPS7 > HMBS
gN(M) YWHAZ > B2M > GAPDH > ABL > ACTB > 18S > GUSB > HPRT > RPS7 > HMBS
gN YWHAZ = B2M > ACTB > 18S > GAPDH > ABL > GUSB > HPRT > RPS7 > HMBS
Neoplastic tissues NF RPS7 > ACTB > HMBS > GAPDH > B2M > ABL > 18S > GUSB > YWHAZ > HPRT
gN(M) ACTB > RPS7 > HMBS > GAPDH > B2M > 18S > ABL > GUSB > YWHAZ > HPRT
gN GAPDH = HMBS > 18S > RPS7 > ACTB > B2M > ABL > GUSB > YWHAZ > HPRT
The expression stability is given as stability values calculated by NormFinder (NF), M values calculated by geNorm (gN(M)), and geNorm 
calculations (gN). Rankings are shown from most (left) to least (right) stable genes.BMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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philin A, the TATA box binding protein or the transferring
receptor CD71, were not included because they are regu-
lated by or known to interact with retroviruses [30-33];
the latter are a major research interest of our group.
Recently it was reported that nine of the ten selected
genes, i.e., ACTB, ABL, B2M, GAPDH, GUSB, HMBS,
HPRT, YWHAZ, and the 18S rRNA gene, are assumed not
to be co-regulated [19,34,35].
Processed pseudogenes are known to hamper data inter-
pretation in mRNA transcription analysis [36,37]. We
therefore included potential reference genes that are
known to lack pseudogenes in humans, i.e., ABL, B2M,
GUSB, and HMBS [36,38]. We confirmed that these four
genes also lack pseudogenes in the cat (at least for the
sequences included in our assays). For the other four
newly developed assays (ACTB, HPRT, RPS7, and
YWHAZ), we demonstrated the presence of processed
pseudogenes. For feline GAPDH the presence of one copy
of a pseudogene had been reported earlier [39]. To mini-
mise co-amplification of pseudogenes, gDNA contamina-
tion of the assayed RNA was reduced to a minimum by
choosing the optimal RNA extraction method for each tis-
sue. The inclusion of a DNase digestion step was omitted
because it significantly reduced the RNA yield. The
absence of a DNase treatment and thus the presence of
sufficient amounts of RNA may explain why the PCR sig-
nals were clearly above background for all samples, in
contrast to other reports in which HPRT, ABL, or HMBS
could not (reliably) be detected [17,40].
We designed the eight new assays to span an exon-exon
junction in order to reduce the possible interference of
gDNA - including conventional but not processed pseu-
dogenes. The assays for those four potential reference
genes lacking processed pseudogenes did not amplify
gDNA, with the exception of GUSB. For the latter, the
amplicon size from gDNA was only 532 bp due to a short
intron and the primer design software had positioned the
exon-exon junction only three nucleotides before the 3'
end of the probe (Table 2).
The expression level of an ideal reference gene should not
undergo tissue-specific and experimentally-dependent
variation and should be similar to that of the target genes
[16-19,41,42]. The RNA transcription levels of the ten
selected candidate reference genes in the blood samples
and 15 tissues differed considerably, but most of them
were within a range that could be used for proper normal-
isation of many target genes. Only the 18S rRNA gene
expression level was impracticably high. Significant differ-
ences were found when the expression levels of the poten-
tial reference genes were analysed in different tissues.
GAPDH expression was higher in brain, myocardium, and
blood samples; this is consistent with results reported for
human tissues [19,43]. B2M expression was significantly
higher in blood. This has also been demonstrated for
human leukocytes [19].
The expression stability of the tested reference genes was
calculated using the NormFinder and the geNorm soft-
ware. The geNorm uses a pairwise comparison model that
provides a combination of two genes whose expressions
are most correlated in the tested sample [19], while the
ANOVA-based model of the NormFinder program selects
the highest ranked gene based on the highest expression
stability due to minimal estimated intra- and intergroup
variation [23]. Using the geNorm, co-regulated genes may
become highly ranked independent of their expression
stabilities [23]. In contrast, the ANOVA-based approach is
not significantly affected by co-regulation of candidate
reference genes [23]. Therefore, the differences found
between the reference gene rankings automatically pro-
duced by the two programs may indicate that at least
some of the examined genes were co-regulated. A better
agreement was found between the automatic NormFinder
ranking and the ranking performed manually using the
geNorm  M  values. To our knowledge, the differences
observed between the automatically calculated geNorm
gene ranking and the ranking using the M values of the
geNorm program has not been reported previously.
Studies of the validation of reference gene expression have
been performed for different mammalian species includ-
ing humans [17,19,38,44], companion animals
[13,14,45,46], farm animals [47-50], and horses [51,52].
No general best reference gene has been found for all spe-
cies. Moreover and in agreement with findings from other
species [17,41,42,53], in the cat no single gene was suita-
ble for accurate normalisation in all investigated tissues.
This highlights the need for proper validation of reference
genes in the respective tissues preceding any experimental
set-up. It has been demonstrated that normalisation of
data sets with different reference genes, such as GAPDH
and ACTB, may influence the outcome of the study; the
expression profiles of target genes were markedly influ-
enced and statistically significant differences between
study groups were present or absent depending on the
choice of the reference genes [54-56].
For the majority of the examined feline healthy tissues
RPS7, ACTB, and ABL were among the most stably
expressed genes. When all healthy tissues were combined
for analysis, the three most stable genes were RPS7, GUSB,
and YWHAZ. These results are only partially in agreement
with those of a recent validation of feline reference genes
using SYBR Green real-time PCR assays and pairwise anal-
ysis [13]. In the latter study, RPS7 was also found as the
most stable gene in six tissues under investigation;
YWHAZ ranked fourth (after two ribosomal protein genes
not included in the present study), and GUSB was found
among the least stable genes; ACTB and ABL were notBMC Molecular Biology 2009, 10:106 http://www.biomedcentral.com/1471-2199/10/106
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examined [13]. Three feline tissues were included in both
the previous [13] and the present study. While for the kid-
ney a partial agreement was found in the gene ranking
(RPS7 and YWHAZ were among the stable ones; HPRT
and GAPDH were rather unstable), the results for liver
and myocardium differed significantly. The observed dis-
crepancy may be (apart from the differences in the applied
PCR and mathematical methods) due to the tissues under
investigation. We based our evaluation primarily on tis-
sues from healthy cats. In contrast, the study from Pen-
ning and co-workers [13] used mainly pathological
tissues. Pathological processes can alter the expression lev-
els of reference genes [55,57], therefore it is of importance
to evaluate potential reference genes in healthy tissues.
Generally, healthy tissues are included in most study
design as internal controls. Thus, with the present study,
we provide baseline data on reference genes for many
future studies investigating feline tissues. Furthermore,
the number of samples studied may have influenced the
evaluation: in the previous study, for the majority of the
tissues, a small number of identical samples (i.e. kidney:
n = 2 healthy tissue; n = 3 tumours; n = 3 chronic kidney
failure) was available [13].
Although in the present study B2M in general was not a
very stable reference gene in the tissues, it ranked second
to fourth in stability in the blood samples. This would
confirm a finding in human blood cells, where B2M
seemed a good choice for normalisation in leukocytes,
while it was one of the least stable genes in tissues [19].
For the neoplastic tissues, only a limited number of sam-
ples from FeLV-infected cats with malignant lymphoma
and leucosis were available. The gene ranking order but
not the expression levels of the reference genes in the neo-
plastic tissues differed significantly from those in the
healthy tissues. Nonetheless, the two most stable genes in
the neoplastic tissues (RPS7 and ACTB) were identical to
those in the investigated healthy tissues. Thus, these two
genes could serve as a good first choice to be tested in neo-
plastic tissues in future studies.
Using the geNorm program, we calculated that two to
three reference genes were required for accurate normali-
sation in most tissues. According to Vandesompele and
co-workers, using the three best reference genes is a valid
normalisation strategy in most cases; it results in much
more accurate and reliable normalisation than the use of
only one reference gene does [19]. The use of a limited
number of reference genes is also supported by the finding
that no significant effect on the relative quantity of the tar-
get gene expression was demonstrated when using the
combination of the two best genes compared to using five
of the six most stable genes [34].
From our results, we recommend consulting the literature
for appropriate reference genes according to the tissues
and species under investigation. If healthy tissues are
included in the study design (e.g. baseline values, negative
controls) the reference genes should be evaluated in
healthy individuals. If the corresponding data is not avail-
able, preliminary experiments for the identification of
optimal reference genes are necessary. If this is impossi-
ble, we recommend using RPS7 as the primary choice for
a reference gene in feline tissues (with tissue-specific lim-
itations documented in the present study); results should
be confirmed using other reference genes, such as ACTB,
ABL, GUSB, and/or YWHAZ.
Conclusions
In this study, we investigated the most reliable feline ref-
erence genes for normalisation of gene expression data in
blood samples and 15 different tissues, including endo-
crine, lymphatic, and gastrointestinal tissues, using real-
time TaqMan® PCR assays and pair-wise and ANOVA-
based analyses. Our results indicated that stability of the
reference genes varies among the different tissues, and no
gene was found among the most stable ones for all the tis-
sues under investigation. Moreover, significant differences
were found using either pair-wise or ANOVA-based anal-
ysis approaches. The three most stable genes were RPS7,
ACTB, and ABL, while B2M, HPRT, and the 18S rRNA
gene were the least stable ones. The frequently used
GAPDH had an acceptable stability in a few tissues. These
data emphasise the need for proper validation of candi-
date reference genes in the respective tissues and species in
healthy individuals preceding the initiation of any exper-
imental gene expression study.
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3-monooxygenase/tryptophan 5-monooxygenase activa-
tion protein, zeta polypeptide.
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